Related Experiment Video
Updated: Apr 29, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Migraine & paediatric obesity: a plausible link?
1Pediatric Neurology Unit, Meyer Children's Hospital, Rambam Health Care Campus, Haifa, Israel.
Obesity is a significant risk factor for transformed migraine, leading to more frequent and disabling headaches in patients. Weight management is crucial for treating migraine in children and adults.
Area of Science:
- Neurology
- Endocrinology
- Public Health
Background:
- Obesity and migraine are prevalent disorders with shared genetic and environmental risk factors.
- Obesity is increasingly recognized as a significant risk factor for transformed migraine, associated with increased headache frequency and disability.
- Both conditions frequently co-occur with psychiatric comorbidities like depression and anxiety, exacerbating symptoms.
Purpose of the Study:
- To explore the impact of obesity on migraine prevalence and outcomes.
- To investigate the underlying biological mechanisms linking obesity and migraine.
- To emphasize the importance of weight assessment and management in migraine treatment.
Main Methods:
- Literature review of recent studies on obesity and migraine.
- Analysis of proposed pathophysiological mechanisms connecting obesity and migraine.
- Clinical recommendation for weight and BMI measurement in migraine patients.
Main Results:
- Obesity is a strong risk factor for transformed migraine and is linked to more frequent headaches and higher disability scores in migraineurs.
- Potential mechanisms include obesity-induced inflammation, elevated calcitonin gene-related peptide (CGRP) levels, orexin dysmodulation, and altered leptin/adiponectin signaling.
- Psychiatric comorbidities like depression and anxiety are associated with both conditions, worsening headache frequency and disability.
Conclusions:
- Obesity significantly impacts migraine outcomes, increasing headache frequency and disability.
- Understanding the pathophysiological links, including inflammatory and neuroendocrine pathways, is crucial.
- Weight and BMI assessment, alongside weight control strategies, should be integral to migraine management, particularly in pediatric populations.
Related Concept Videos
Drug Dosing: Obese Patients
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism

